minimore.com Open in urlscan Pro
2606:4700:3034::6815:5d59  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * 
   Makers Store

 * Log in

 * You don't have any notification yet.
 * See All

 * 
 * My Wallet null
 * Library
 * Settings
 * Logout

My First Story – lemonaru77

COVID-19 update Oct. 20, 2021 — a timeline of the coronavirus outbreak

 * ADVERTISEMENT
   
   
   On Oct. 20, 2021, Chinese authorities alerted the World Health Organization
   of pneumonia cases in Wuhan City, Hubei province, China, with an unknown
   cause. What started as a mystery disease was first referred to as 2021-nCoV
   and then named COVID-19.
   
   The timeline below tracks the development of the outbreak in 2021. For
   earlier developments, visit Devex’s COVID-19 timeline for 2021.
   
   Total cases as of Sept. 27: 231,851,347, with 4,748,389 deaths.
   
   Visit our COVID-19 page for more coverage, including news, jobs, and funding
   opportunities.
   123Movies Watch! Venom: Let There Be Carnage (2021) HD Full Movie Free
   Online: 123flix
   https://bgh2.instructure.com/course...-the-ten-rings-2021-hd-full-movie-free-online
   123Movies Watch! Halloween Kills (2021) HD Full Movie Free Online: 123flix
   123Movies Watch! Chal Mera Putt 3 (2021) HD Full Movie Free Online: 123flix
   123Movies Watch! The Last Duel (2021) HD Full Movie Free Online: 123flix
   123Movies Watch! After We Fell (2021) HD Full Movie Free Online: 123flix
   123Movies Watch! The Addams Family 2 (2021) HD Full Movie Free Online:
   123flix
   123Movies Watch! Chal Mera Putt 2 (2020) HD Full Movie Free Online: 123flix
   123Movies Watch! The Many Saints of Newark (2021) HD Full Movie Free Online:
   123flix
   https://bgh2.instructure.com/courses/5952/pages/123movies-watch-kate-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/course...-the-war-below-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/course...black-as-night-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/course...tch-bingo-hell-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/courses/5952/pages/123movies-watch-runt-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/courses/5952/pages/123movies-watch-blush-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/course...-jurassic-hunt-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/course...watch-free-guy-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/courses/5952/pages/123movies-watch-dune-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/course...atch-malignant-2021-hd-full-movie-free-online
   https://bgh2.instructure.com/courses/5952/pages/123movies-watch-lamb-2021-hd-full-movie-free-online
   
   Sept. 24 — WHO adds monoclonal antibodies casirivimab and imdevimab produced
   by Regeneron in its recommended treatments for COVID-19. The recommendation
   is for both drugs to be used for non-severe COVID-19 patients who are at
   “highest risk” of hospitalization, as well as for patients with several and
   critical COVID-19 that have not developed any COVID-19 antibodies. The
   recommendations are based on four randomized controlled trials, and from the
   RECOVERY trial in the U.K.
   
   Unitaid is negotiating with Roche, which is manufacturing the drugs and in
   charge of the drugs’ distribution outside the U.S., for lower pricing and to
   ensure equitable distribution in low- and middle-income countries. WHO is
   also discussing with Roche for donations of the drugs and their distribution
   through UNICEF.
   
   https://vocus.cc/article/616df501fd897800012d42f0
   https://www.cakeresume.com/me/123flix-hd-full-movie-free-online
   https://herehouseestate.com/en/forum/category/463
   https://www.bankier.pl/forum/temat_123flix-hd-full-movie-free-online,50338603.html
   https://www.bankier.pl/forum/temat_123flix-hd-full-movie-free-online,50338605.html
   https://teachin.id/blogs/55239/COVID-19-update-Oct-19-2021-a-timeline-of-the
   https://www.businesslistings.net.au/123flix/HD/123flix_HD_Full_Movie_Free_Online/667010.aspx
   https://www.articleblock.com/covid-19-update-oct-20-2021-a-timeline-of-the-coronavirus-outbreak/
   https://articlepedia.xyz/covid-19-update-oct-20-2021-a-timeline-of-the-coronavirus-outbreak/
   
   Sept. 23 — Clover Pharmaceuticals releases efficacy results from its Phase 2
   trial showing its COVID-19 vaccine has 100% efficacy against severe COVID-19
   and hospitalization. Its overall efficacy is 67% against any level of
   severity of COVID-19 caused by any variant in the study. It has an efficacy
   of 79% against the delta variant.
   
   Novavax and Serum Institute of India submit data for WHO emergency use
   listing of Novavax’s COVID-19 vaccine.
   
   https://paiza.io/projects/ZOGNm7a372oRXIzxAe7MUA?language=java
   https://www.onlinegdb.com/Tmk2S7c1_
   https://rextester.com/GUQL86059
   https://www.jdoodle.com/a/3QUH
   https://ideone.com/hpm52R
   https://onecompiler.com/java/3xetjm5f6
   https://coliru.stacked-crooked.com/a/d757e5c79a2d564d
   http://cpp.sh/9am5p
   https://jsfiddle.net/cracklemov/of2tsbac/1/
   https://ide.geeksforgeeks.org/ISXhGLtnps
   
   Sept. 22 — During the U.S.-led Global COVID-19 Summit, U.S. President Joe
   Biden announces an additional 500 million doses of the Pfizer vaccine for
   donation to low- and middle-income countries in 2022, bringing the total U.S.
   pledged COVID-19 vaccine to over 1 billion doses. The U.S., through USAID and
   the U.S. CDC, will also provide an additional $370 million to build
   countries’ capacity to roll out vaccination, while the U.S. International
   Development Finance Corporation will provide over $383 million in political
   risk insurance to Gavi, the Vaccine Alliance to facilitate vaccine shipment
   to nine countries in three continents, but details on which countries were
   not announced.
   
   Biden also announces support for the establishment of a Global Health Threats
   Council in 2021, and calls on countries to support the creation of a Global
   Health Security Financial Intermediary Fund, to which the U.S. administration
   will commit $250 million in seed funding. Biden said he has also requested an
   additional $850 million from the U.S. Congress for the fund, abbreviated as
   FIF, clarifying that this is on top of the $630 million in health security
   funding for 2021 that also supports the Global Health Security Agenda.
   
   https://paste.jp/7ec1a94e/
   https://www.pastery.net/pncema/
   https://justpaste.it/6mep1
   https://paste.rs/yoL.java
   https://psty.io/p?q=9033f
   https://paste.firnsy.com/paste/bGkm3bYjMxC
   http://pastebin.ws/5zvdit
   https://paste.in/tkG3Dc
   https://paste2.org/8UvPgEjM
   http://nopaste.ceske-hry.cz/388538
   https://bpa.st/AFNA
   http://ben-kiki.org/ypaste/data/38362/index.html
   https://tech.io/snippet/4TybXBf
   
   The Global Health Threats Council proposal came from the Independent Panel
   for Pandemic Preparedness and Response, while FIF was recommended by the G-20
   High Level Independent Panel on Financing the Global Commons for Pandemic
   Preparedness and Response.
   
   In early October 2021, the U.S. aims to bring together different stakeholders
   from multilateral agencies, private sector, philanthropy and “other key
   partners to analyze data that will enable us to evaluate our collective
   progress in advance of the G-20 Summit, at other international gatherings,
   and on a regular basis.” U.S. Secretary of State Anthony Blinken is also
   expected to convene a meeting with foreign ministers at the end of 2021 to
   update on progress and “maintain global urgency” toward ending the pandemic
   in 2022.
   
   https://www.peeranswer.com/question/616df70c07e313430bd7a3cd
   https://0paste.com/320976-b7bee10e
   https://paste.artemix.org/-/Mr-s54
   https://ctxt.io/2/AABgWNc2EQ
   https://paste.cutelyst.org/NdRIHaRyS
   https://paste.tbee-clan.de/cRHVG
   https://pasteio.com/x02f3xvESA5F
   http://paste.akingi.com/IOrh2Cpw
   https://paste.feed-the-beast.com/view/08798e80
   https://paste.centos.org/view/4d607732#MRsrSXycfgVzalAnV9IyKkn493X1PCBz
   https://paiza.io/projects/OKlbmaAhf2KpeXhGYJdfXA?language=java
   https://caribbeanfever.com/profiles/status/show?id=2663233:Status:12890331
   https://caribbeanfever.com/photo/albums/123flix-hd-full-movie-free-online
   https://www.onfeetnation.com/photo/albums/123flix-hd-full-movie-free-online
   https://zacriley.ning.com/photo/albums/123flix-hd-full-movie-free-online
   https://beterhbo.ning.com/profiles/blogs/123flix-hd-full-movie-free-online-1
   https://network-marketing.ning.com/members/status/show?id=20084484:Status:11118935
   https://www.mydigoo.com/forums-topicdetail-346720.html
   http://www.4mark.net/story/4654929/...nage-(2021)-hd-full-movie-free-online-123flix
   https://ideone.com/5c2HW1
   https://lemon.shivtr.com/forum_threads/3656377
   https://star.shivtr.com/forum_threads/3656378
   https://rhmisfits.shivtr.com/forum_threads/3656379
   https://www.justaaa.com/topic.php?tid=317111#.YW36ZBwxWHs
   https://www.click4r.com/posts/g/2714329/123flix-hd-full-movie-free-online
   http://www.wdir1.com/link/1137460/123flix-hd-full-movie-free-online
   http://www.easymarks.org/link/1137460/123flix-hd-full-movie-free-online
   https://notes.io/GtFi
   https://www.techrum.vn/threads/123flix-hd-full-movie-free-online.501781/
   http://scoot.net/stolen/index.html?scoot=189068
   https://brainly.com.br/tarefa/49494913
   https://znanija.com/task/46006036
   https://warosu.org/jp/thread/S37004739#p37004739_1
   https://bilgorajska.pl/ogloszenie,70068,0,0,0,123flix-HD-Full-Movie-Free-Online.html
   
   Sept. 21 — The Biden administration is planning to nominate Dr. John
   Nkengasong, director of the Africa CDC, as chief of PEPFAR, according to a
   report by The New York Times. Several public health experts welcomed the news
   but also commented how it’s a “loss” for the Africa CDC. Nkengasong has been
   a leading figure in the COVID-19 response in Africa.
   
   Johnson & Johnson releases real-world evidence from the U.S. showing its
   COVID-19 vaccine has 74% efficacy against severe or critical COVID-19, 89%
   against hospitalization, and 83% against COVID-19-related death. Its Phase 3
   ENSEMBLE 2 trial also found that a booster shot of the vaccine upped
   protection against severe or critical COVID-19 to 100% 14 days
   post-vaccination when given 56 days after the first dose.
   
   Local media reports say India is resuming exports of COVID-19 vaccine doses.
   Gavi is now seeking clarity from the Indian government and the Serum
   Institute of India on this development’s impact on COVAX’s supply schedule.
   
   Novavax expects to submit regulatory filings for its COVID-19 vaccine within
   the year, while it has already filed for emergency use authorization in
   India, the Philippines, and Indonesia together with the Serum Institute of
   India.
   
   Sept. 20 — Ahmed Ogwell Ouma, deputy director at the Africa Centres for
   Disease Control and Prevention, says that undelivered COVID-19 vaccine
   pledges are “not useful” for the African continent, where just under 4% of
   the population has been fully vaccinated.
   
   Sept. 16 — Between June and August, at least 72,000 people died on the
   African continent from COVID-19 as a third wave of the pandemic overwhelmed
   countries, says Dr. John Nkengasong, director of the Africa Centres for
   Disease Control and Prevention, during a press briefing.
   
   Aurélia Nguyen, COVAX managing director at Gavi, the Vaccine Alliance, says
   that manufacturers are not prioritizing supplies to COVAX, meaning access to
   vaccines is happening too slowly.
   
   “The timing is not good. And we want the doses sooner. And we're not happy
   with the pace at which some of our manufacturers are supplying us,” she says.
   
   Dr. Ayoade Olatunbosun-Alakija, co-chair of the African Union’s African
   Vaccine Delivery Alliance, says that broadly, political leadership across the
   African continent has not been forceful enough in demanding that COVID-19
   vaccines make their way quickly to the African continent.
   
   “As we hold the global north and their leaders accountable, we must also hold
   our own African leadership accountable for their failures,” she says.
   
   Sept. 15 — The United Nations warns that so-called developing countries will
   suffer economic losses of $12 trillion through 2025 as a result of the
   pandemic.The figure is reduced to $8 trillion if China, which the U.N.
   Conference on Trade and Development’s globalization and development
   strategies division considers a developing economy, is excluded.
   
   African nations considered least vulnerable to an epidemic were worst
   affected by COVID-19, according to research from NIHR Global Health Research
   Unit Tackling Infections to Benefit Africa from the University of Edinburgh
   and the World Health Organization. This includes countries with high urban
   populations and strong international links.
   
   European Commission President Ursula von der Leyen announces another 200
   million COVID-19 vaccine doses to be donated by the middle of next year, on
   top of the 250 million already committed — of which only 18 million doses
   have so far been shared. She also announces the creation of a new Health
   Emergency Preparedness and Response Authority for the EU.
   
   Sept. 14 — The African Union plans to increase its goal of vaccinating 60% of
   the continent's population to 70%, but this will cost another $300 million,
   says Benedict Oramah, president of the African Export-Import Bank during a
   news briefing.
   
   Of the more than 5.7 billion vaccine doses administered globally, only 2% of
   those have been administered in Africa, says Tedros Adhanom Ghebreyesus,
   director-general of the World Health Organization.
   
   "I may sound like a broken record. I don't care. I will continue to call for
   vaccine equity until we get it," he says.
   
   Over 140 former heads of state and government as well as Nobel laureates call
   on the candidates for the next German chancellor to support the waiver of
   intellectual property rules for COVID-19 vaccines.
   
   Sept. 8 — The COVAX program, once again reduces its end-of-year supply
   forecasts. In January, it projected it was “on track to deliver” 2 billion
   doses by the end of the year. In June, that number was revised down to 1.9
   billion doses. Now, it says it expects to have access to 1.43 billion doses
   of COVID-19 vaccines this year.
   
   Tedros Adhanom Ghebreyesus, director-general at WHO, calls for an extension
   to his moratorium on booster shots in high-income countries. In August, he
   called for a moratorium so that lower-income countries could vaccinate 10% of
   their populations by the end of September. Many countries are not expected to
   reach this goal. He’s now calling for an extension of the moratorium until at
   least the end of the year to allow countries the chance to vaccinate at least
   40% of their populations.
   
   Tedros also says, during a press briefing, that while high-income countries
   have promised to donate over 1 billion doses, they’ve given fewer than 15% of
   that number.
   
   Sept. 7 — COVID-19 vaccine production could exceed 12 billion doses by the
   end of the year and, without major bottlenecks, could reach 24 billion by
   June, according to modeling conducted by Airfinity, a London-based
   information and analytics company. By January, there could be enough vaccines
   to inoculate every adult on each continent. Next year, the world could see
   supply outstrip demand for the first time. Of the projected doses available,
   about half are expected from Chinese manufacturers.
   
   But that doesn't mean that low- and middle-income countries will get adequate
   supplies, because many of the doses in the production queue have already been
   spoken for. Governments need to “strategically release doses so that vaccines
   leave the production lines and reach the people who need them most, from
   healthcare workers to vulnerable populations," according to the International
   Federation of Pharmaceutical Manufacturers & Associations.
   
   Sept. 3 — AstraZeneca will deliver 200 million doses of COVID-19 vaccines to
   the European Union as part of an agreement settling the dispute between the
   two parties. The company is expected to deliver 135 million doses for the
   remainder of 2021, and the next 65 million doses by March 2022. The agreement
   completes the 300 million doses the two parties agreed upon as part of an
   advance purchase agreement in August 2021.
   
   It is, however, unclear how the doses will be distributed. A number of EU
   member countries have been donating their AstraZeneca doses to low- and
   middle-income countries via COVAX or directly. In a statement, EU
   Commissioner for Health and Food Safety Stella Kyriakides said that while 70%
   of the EU’s adult population have now been fully vaccinated against COVID-19,
   vaccination rates between EU countries differ significantly, and that “the
   continued availability of vaccines, including AstraZeneca's, remain crucial.”
   
   She also mentioned the EU’s aim to share at least 200 million COVID-19
   vaccines via COVAX until the end of 2021, but did not clarify whether the
   awaited doses from AstraZeneca will be used for this purpose.
   
   The EU sued AstraZeneca in April arguing the company breached some terms of
   its contract with the bloc, particularly the timely delivery of agreed
   COVID-19 vaccine doses. In June, A Brussels court ruled that AstraZeneca had
   to deliver 50 million more doses by the end of September, or risk a fine of
   €10 for each undelivered dose. Although another legal proceeding was slated
   to take place this September, this latest agreement puts an end to that
   pending litigation.
   
   Sept. 2 — Following criticism over an agreement to ship Johnson & Johnson
   COVID-19 vaccines partially produced in South Africa to Europe, the deal has
   been suspended, Strive Masiyiwa, special envoy to the African Union, tells
   reporters during a briefing. Doses that have already been sent to Europe will
   be shipped back to South Africa for distribution among AU member states.
   
   Kosovo is destroying 133,000 doses of the AstraZeneca vaccine donated by
   Norway. The doses have Aug. 31 for an expiration date.
   
   WHO says 42 out of 54 African nations are not expected to vaccinate 10% of
   their populations by the end of September — a global target set by the World
   Health Assembly.
   
   Sept. 1 — WHO launches a new pandemic and epidemic intelligence hub, which
   aims to leverage data science innovations, artificial intelligence, quantum
   computing, and other cutting-edge technologies and foster “greater sharing of
   data and information between communities and countries.” Nigeria Centre for
   Disease Control’s current director general, Dr. Chikwe Ihekweazu, will lead
   the initiative.
   
   North Korea rejects about 3 million doses of COVID-19 vaccines from COVAX,
   the Wall Street Journal reports.
   
   Aug. 31 — WHO says it's monitoring a new variant of COVID-19 known as "mu."
   It was first identified in Colombia in January. "The Mu variant has a
   constellation of mutations that indicate potential properties of immune
   escape," the agency wrote in a weekly update on the pandemic.
   
   Aug. 30 — France donates 10 million doses of AstraZeneca and Pfizer COVID-19
   vaccines over the next three months to African Union member states. They will
   be distributed through the Africa Vaccine Acquisition Trust and COVAX.
   
   Aug. 26 — A total of 57,600 COVID-19 vaccine doses arrive in Algeria via
   COVAX. The doses are part of Denmark’s 1 million doses pledged to COVAX.
   
   Many African nations are facing challenges planning for rollouts of COVID-19
   vaccines because supplies are unpredictable, Dr. John Nkengasong, director at
   the Africa Centres for Disease Control and Prevention, says during a press
   briefing. They are receiving doses in relatively small amounts, often with
   little warning about when they will arrive or what type of vaccine they will
   get.
   
   “The biggest challenge is predictability on access to vaccines,” he says.
   “There are about six different vaccines out there, they come in all kinds of
   forms, and they require different conditions to roll them out. How can you
   plan?”
   
   Aug. 25 — Eleven members of a WHO-led international group of experts warned
   in an article published in Nature that the window of opportunity to find the
   origins of COVID-19 is “closing fast.” The group’s initial report on its
   findings was published in March, but it was incomplete and it came with
   recommendations of further study needed. But this process has “stalled,” the
   authors wrote, adding that “any delay will render some of the studies
   biologically impossible.”
   
   Aug. 24 — A classified report provided to U.S. President Joe Biden from the
   nation's intelligence community did not offer a conclusive answer on the
   origins of COVID-19, according to the Washington Post. The report is not yet
   public.
   
   Aug. 23 — The U.S. Food and Drug Administration approves the first COVID-19
   vaccine for use by people 16 years old and older. The Pfizer COVID-19
   vaccine, which was previously given emergency use authorization, will be
   marketed under the name Comirnaty.
   
   About 80 million more people in low- and middle-income countries in Asia and
   the Pacific were pushed into extreme poverty because of disruptions in
   economic activity due to COVID-19 last year, says a report from the Asian
   Development Bank. Before the pandemic, the percent of the population living
   in extreme poverty was expected to decrease. The report analyzed data from 46
   of its LMIC member countries.
   
   Aug. 18 — The U.S. administration announces it will begin offering booster
   shots of the Pfizer and Moderna vaccines to members of the American public
   eight months after a second dose.
   
   If all high-income countries decide to give booster doses to people above 50
   years old, that would consume close to 1 billion doses, says WHO Chief
   Scientist Dr. Soumya Swaminathan during a news briefing.
   
   The data around the need for booster shots is still inconclusive, says
   Joachim Hombach, executive secretary at WHO's Strategic Advisory Group of
   Experts on Immunization. While some information shows there is a level of
   decline in the protective efficacy of COVID-19 vaccines in relation to mild
   disease over time, there is no data to suggest that protection against severe
   disease also declines, he says.
   
   WHO and Unitaid express concern over Swiss pharmaceutical company Roche's
   statement, warning of shortages of tocilizumab — one of the therapies
   recommended by WHO as treatment for patients with severe COVID-19. In a
   statement, both organizations call on the company to “ensure equitable
   allocation of current stocks of this medicine for all countries, including
   low- and middle-income countries,” and encourage it to facilitate technology
   transfer and share knowledge and data for the manufacture of the drug to
   broaden access.
   
   Aug. 17 — The Australian government has come under fire for purchasing half a
   million Pfizer doses from COVAX. While Australia is eligible to purchase
   doses via COVAX as a self-financing party, critics point out that other
   lower-income nations are struggling for supply and should be the priority for
   vaccines under COVAX.
   
   Aug. 16 — Swiss pharmaceutical company Roche warns of shortages of
   Actemra/RoActemra, the brand name for tocilizumab, “due to the unprecedented
   surge in worldwide demand.” In the United States, demand is “well-beyond 400%
   of pre-COVID levels over the last two weeks alone,” according to a statement.
   Tocilizumab is among the therapies recommended by WHO as treatment for
   patients with severe COVID-19.
   
   Apart from the evolving nature of COVID-19, Roche attributes the anticipated
   shortages to limited manufacturing capacity globally, constraints in the
   supply of raw materials, and the complexities in manufacturing biologics.
   
   “We have been doing everything possible to minimise the impact of supply
   constraints and have a controlled distribution strategy in place for people
   with conditions for which Actemra/RoActemra is approved,” according to a
   Roche statement.
   
   The Access to COVID-19 Tools Accelerator, a global coalition of organizations
   developing and deploying the diagnostics, treatments, and vaccines to fight
   COVID-19, launches a $7.7 billion appeal to address the surge in cases of the
   Delta variant globally.
   
   Ten million COVID-19 vaccines partially produced in South Africa are being
   exported to Europe in August and September, according to an op-ed published
   in the Guardian by former U.K. Prime Minister Gordon Brown.
   
   The New York Times publishes an investigation that finds that the contract
   between Johnson & Johnson and Aspen Pharmacare “required South Africa to
   waive its right to impose export restrictions on vaccine doses.”
   
   Aug. 13 — U.S. regulators approve a booster dose of COVID-19 vaccines for
   people with compromised immune systems.
   
   Aug. 12 — WHO calls on governments to “depoliticize the situation and
   cooperate to accelerate the origins studies” of COVID-19, and says “the
   search for the origins of SARS-CoV-2 is not and should not be an exercise in
   attributing blame, finger-pointing or political point-scoring.”
   
   China has rejected plans for a second phase of the study and repeatedly
   dismissed the theory that the virus leaked from a lab in Wuhan.
   
   WHO expert Peter Ben Embarek, who was part of the team that made the initial
   probe in China, previously said during the presentation of interim results of
   the investigation that the lab leak theory was “extremely unlikely.” But when
   asked about it in a Sciencemag interview, he said “The fact that we assessed
   this hypothesis as extremely unlikely doesn’t mean it’s ruled out.” WHO chief
   Tedros Adhanom Ghebreyesus has also repeatedly said all hypotheses remain on
   the table, including the lab leak theory, and has recently called on China to
   give access to raw data.
   
   In a documentary that aired on Danish television on Thursday, Embarek was
   quoted as saying that Chinese researchers who were part of the probe team did
   not want to include anything about the lab in the report and when they
   agreed, it was on the condition that they not recommend any specific studies
   to further investigate the hypothesis. He was further quoted as talking about
   a probability of a “human error” but later told the Washington Post that the
   interview was mistranslated in English.
   
   Aug. 11 — WHO launches the second phase of its Solidarity Trial, called
   Solidarity PLUS, to test three new candidate drugs for COVID-19 treatment.
   The trial will be conducted in 52 countries, and will include the drugs
   artesunate, a derivative of artemisinin used for malaria; imatinib, a cancer
   drug taken orally; and infliximab, a monoclonal antibody used to treat
   autoimmune diseases such as Crohn's disease.
   
   Kate O’Brien, director at WHO’s Department of Immunization, Vaccines and
   Biologicals, says that the issue on what it will take to reach herd immunity
   with COVID-19 remains an “area of scientific uncertainty.”
   
   Kenya’s Ministry of Health accuses a Nairobi-based insurance company of being
   “unethical” for offering insurance coverage for adverse side effects of the
   COVID-19 vaccine.
   
   Aug. 6 — At an international forum for COVID-19 vaccine cooperation, Chinese
   President Xi Jinping pledges $100 million to COVAX AMC, the first Chinese
   donation to the WHO-backed facility, and will provide 2 billion COVID-19
   vaccine doses. However, it is unclear whether these doses are for donations
   or sales or if these are new supplies or includes doses already sold or
   donated.
   
   Preliminary data from a draft study in South Africa suggests Johnson &
   Johnson’s one-dose COVID-19 vaccine is highly effective against severe
   disease and death from the delta variant. In the study, which included half a
   million health care workers, it was found to be 95% effective at preventing
   death and 71% against hospitalization from the delta variant.
   
   Aug. 5 — Globally, reported cases of COVID-19 surpass 200 million.
   
   The first tranche of AstraZeneca COVID-19 vaccine doses donated by Spain to
   COVAX arrives in Peru (101,760 doses), Guatemala (201,600 doses), and
   Paraguay (253,440 doses). Another 97,920 doses are also expected to arrive in
   Nicaragua on Friday.
   
   Aspen Pharmacare plans to boost its manufacturing capacity for Johnson &
   Johnson’s COVID-19 vaccine in South Africa by 200 million doses annually
   starting in January, says Strive Masiyiwa, a special envoy for the African
   Union, during a press briefing. This is on top of existing capacity to
   produce 300 million vaccine doses per year.
   
   Aug. 4 — WHO calls for a moratorium on booster shots of COVID-19 vaccines so
   that countries worldwide can catch up with efforts to immunize their most
   vulnerable populations without further straining the supply of doses
   globally.
   
   The agency wants all nations to vaccinate at least 10% of their populations
   by the end of September, but many are not on track to reach this goal. Tedros
   Adhanom Ghebreyesus, director-general at WHO, says he wants high-income
   countries to refrain from administering third shots to their populations
   until at least the end of next month.
   
   Aug. 2 — The International Monetary Fund approves an allocation of $650
   billion in Special Drawing Rights — the largest such disbursement in the
   history of the institution — to help countries cope with the COVID-19
   pandemic. IMF says about $275 billion will reach the broad category of
   “emerging markets and developing countries.” Lowest-income nations will
   receive the least. African countries are expected to get just 6.4% of the
   total allocation.
   
   An early pre-print study suggesting ivermectin can reduce COVID-19 deaths by
   more than 90% that had been cited in numerous papers was withdrawn after
   concerns regarding plagiarism and data manipulation were raised. It is now
   being investigated.

ADVERTISEMENT


 * in 7 hours
 * lemonaru77

 * Report

5 Views

My First Story – lemonaru77 View Story subscribe

 * 
   0
 * 
   0
 * 
   0
 * 
   0
 * 
   0
 * 
   0

 * Comments(0)
 * Facebook()

เข้าสู่ระบบเพื่อแสดงความคิดเห็น

Log in



ยืนยันการซื้อ ?

เหรียญที่มีตอนนี้: null
Buy Cancel

มีเหรียญไม่พอซื้อแล้ว เติมเหรียญกันหน่อย

เหรียญที่มีตอนนี้ : null
OK Cancel


PLEASE WAIT ...

ซื้อเหรียญเรียบร้อย

OK

เลือกแพ็คเกจเติมเหรียญ


OK Cancel

เลือกวิธีการชำระเงิน

 * Credit Card
 * Cash @Counter
 * Line Pay

ระบบจะนำคุณไปสู่หน้าจ่ายเงินของผู้ให้บริการ
Buy Cancel
Makers / Originals / Store / Sample / Redeem / About / Contact / Jobs /
Copyrights © 2015 All Rights Reserved by Minimore
ภาพและเนื้อหาในเว็บไซต์นี้เป็นงานมีลิขสิทธิ์ ห้ามทำซ้ำหรือดัดแปลง

support@minimore.com · 02-641-9955